BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MDR-001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of MDR-001\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07274137-248@assetmemo.bio
DTSTAMP:20261121T005851Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:MDR-001: Phase 3 readout est. (NCT07274137)
DESCRIPTION:MDR-001\, phase 3\, Obesity.\nStudy: A Phase III Study to Evalu
 ate the Efficacy and Safety of MDR-001 in Adult Participants With Overweig
 ht or Obesity (MOBILE）\nEstimated primary completion: June 2027. This is
  a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can
  move.\nDrug page: https://assetmemo.bio/drug/mdr-001#upcoming-events\nReg
 istry record: https://clinicaltrials.gov/study/NCT07274137
URL:https://assetmemo.bio/drug/mdr-001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
